RIKEN IMS AnnualReport 2020
4/98

IIOrganization .............................................................................IContents ....................................................................................IISignals from two gut bacteria trick the body into Division of Genomic Medicine .......................................8Laboratory for Transcriptome Technology .....................9Laboratory for Cellular Function Conversion attacking its own central nervous system .......................2A quantum leap for lipidomics research ...............................3The impact of mosaic chromosomal alterations on oncogenesis and the aging process: the first findings outside Europe ....................................................................4Technology ..................................................................10Laboratory for Genome Information Analysis ............11Laboratory for Applied Computational Genomics......12Laboratory for Large-Scale Biomedical Data Technology ..................................................................13Laboratory for Advanced Genomics Circuit ................14Genetic Diagnosis Technology Unit Nucleic Acid Diagnosis System Developing Unit .........................15Laboratory for Cellular Epigenomics ............................16Laboratory for Comprehensive Genomic Analysis .....17Laboratory for Applied Regulatory Genomics Network Analysis .......................................................................18Preventive Medicine and Applied Genomics Unit ......19RIKEN-IFOM Joint Laboratory for Cancer Genomics .......................................................20Laboratory for Genotyping Development ....................21Laboratory for Statistical and Translational Genetics .......................................................................22Laboratory for Pharmacogenomics ...............................23Laboratory for Bone and Joint Diseases ........................24Laboratory for Genomics of Diabetes and Metabolism .................................................................25Laboratory for Cardiovascular Genomics and Informatics ..................................................................26Division of Human Immunology ................................27Laboratory for Autoimmune Diseases ..........................28Director’s Report ...................................................................IVLearning how cancer cells evade group 2 innate lymphoid cells .....................................................................5A curious chemokine, CCL5, paradoxically suppresses the action of immune cells, but RUNX-mediated repression of CCL5 augments immune responses in cancer ..............................................................................6Laboratory for Cell Signaling .........................................29Laboratory for Lymphocyte Differentiation .................30Laboratory for Transcriptional Regulation ...................31Laboratory for Immune Cell Systems ............................32Laboratory for Innate Immune Systems .......................33Laboratory for Immune Homeostasis ...........................34Laboratory for Immune Crosstalk .................................35Laboratory for Inflammatory Regulation .....................36Laboratory for Cytokine Regulation ..............................37Division of Disease Systems Biology .........................38Laboratory for Developmental Genetics .......................39Laboratory for Intestinal Ecosystem ..............................40Laboratory for Integrative Genomics ............................41Laboratory for Mucosal Immunity ................................42Laboratory for Gut Homeostasis ....................................43Laboratory for Skin Homeostasis ...................................44Laboratory for Tissue Dynamics ....................................45Laboratory for Metabolomics .........................................46Laboratory for Microbiome Sciences ............................47Laboratory for Integrated Cellular Systems ..................48Drug Discovery Antibody Platform Unit .....................49Division of Cancer Immunology ..................................50Laboratory for Immunogenetics ....................................51Laboratory for Medical Science Mathematics ..............52Laboratory for Cancer Genomics ..................................53Laboratory for Immunotherapy .....................................54Laboratory for Human Disease Models ........................55Part 1Research HighlightsPart 2Lab ActivitiesContents

元のページ  ../index.html#4

このブックを見る